The development of T helper type 1 (Th1) CD4ϩ T cells in the intestinal mucosa is driven by interleukin (IL)-12 produced from activated macrophages and IL-18 produced from activated macrophages and epithelial cells. Each of these two cytokines is important for the mucosal response during intestinal inflammation, but their synergistic effect is not fully understood. To characterize the synergistic effect of IL-12 and IL-18 with respect to human intestinal inflammation, we assessed the effect of IL-12 and IL-18 on lamina propria lymphocytes from normal control subjects (LPL-NL) and patients with Crohn's disease (LPL-CD).
INTRODUCTION
Upon activation with specific antigens, both CD4 and CD8 cells may differentiate into T helper type 1 (Th1) or T helper type 2 (Th2) subsets (1, 2) . Interferon-␥ (IFN-␥) is the main product of Th1 cells, and it has undoubted physiological importance in regulating immune and inflammatory processes (3) . Interleukin-12 (IL-12), a heterodimetric cytokine produced by activated monocytes/macrophages, is prominently involved in Th1 cell differentiation and IFN-␥ production (4, 5) . IL-12 alone induces small amounts of IFN-␥ production from primary human CD4ϩ T cells. In the presence of costimulants such as IL-2, anti-CD3/CD28, mitogens, and specific antigens, IL-12 has the ability to induce large amounts of IFN-␥ production. Interleukin-18 (IL-18) has been isolated from mouse liver by sequential injection of heat-killed Propionebacterium acnes and lipopolysaccharide (6) . IL-18 has been found to have a variety of biological activities, including stimulation of proliferation of activated T cells, enhancement of natural killer cell lytic activity, induction of IFN-␥ production by activated T cells, and promotion of Th1-type responses (7) (8) (9) (10) (11) . In general, the role of IL-18 in IFN-␥ induction is similar to that of IL-12. IL-18 alone induces low levels of IFN-␥ production but has the ability to induce greater amounts of IFN-␥ production in the presence of costimulants.
Cell-mediated immunity and T cell activation are important features of chronic intestinal inflammatory disorders such as Crohn's disease (CD), in which a Th1 response and enhanced IFN-␥ expression and release have been shown (12, 13) . We have demonstrated a mouse colitis model that is produced by immunization with 2,4,6-trinitrobenzenesulfonic acid and mimics the histopathological features of CD to be mediated by Th1 cytokines (14) . Bioactive IL-12 and IL-18 are expressed by lamina propria mononuclear cells of patients with CD, suggesting a pivotal role for these cytokines in this condition (13, (15) (16) (17) . We have recently reported that macrophages infiltrated into the inflamed mucosa of CD patients produce IL-18, and that macrophagederived IL-18 may serve as a potent regulatory factor for intestinal mucosal lymphocytes (18, 19) .
However, the physiological role of IL-12 and IL-18 in the intestinal mucosa is poorly understood. Several in vitro studies have demonstrated IL-12 and IL-18 to increase the proliferative response of lymphocytes preactivated with anti-CD3 monoclonal antibody (mAb) or anti-CD2 mAb (11, 20 -22) . No direct evidence is available, however, to show how IFN-␥ expression and the proliferation of resting lymphocytes are induced and regulated by IL-12 and/or IL-18 in the human intestinal mucosa. Recently, Chikano et al. have reported that combined administration of IL-12 and IL-18, but neither IL-12 nor IL-18 alone, can induce severe inflammation in the small intestinal and colonic mucosa of mice (23) . These results indicate that IL-12 and IL-18 act in a synergistic fashion to induce intestinal inflammation. Furthermore, these results prompted us to evaluate the direct response of lamina propria lymphocytes (LPLs) to cytokines involved in early defense against pathogens or other insults, independently of the T cell receptor (TCR) recognition system.
The present study investigated how responsiveness to IL-12 and IL-18 is induced in mucosal lymphocytes from control subjects and CD patients.
MATERIALS AND METHODS

Patients and Samples
After receiving informed consent, serum samples were obtained from 16 patients with CD and 13 control subjects. The peripheral blood lymphocytes (PBLs) were separated by Vacutainer (Beckton Dickinson, Bedford, MA).
After receiving informed consent, mucosal samples were obtained from inflamed areas of the intestinal mucosa of 29 patients with CD (16 surgical specimens and 13 biopsies). The primary site of involvement was ileal in nine, ileocolonic in 15, and colonic in five patients. Control samples included mucosal samples from macroscopically and microscopically unaffected areas of 17 surgical colonic and ileal specimens of colon cancer patients. Mucosal biopsies were 2-3 mm in size. Histopathological examination revealed no malignancy or inflammation. The mucosa was prepared immediately after stripping from the underlying submucosa by blunt dissection. All experiments were approved by the Keio University Hospital Committee on Human Subjects, Tokyo, Japan. In the CD group of patients, disease activity was defined by a Crohn's Disease Activity Index and endoscopic and histopathological data. (25) .
Cytokines and Monoclonal Antibodies
Preparation of Mucosal Lymphocytes From Intestinal Mucosa
LPLs were isolated from surgically resected intestinal specimens using enzymatic techniques described elsewhere (26, 27) . Briefly, the dissected mucosa was incubated in calcium and magnesium-free Hank's buffered saline solution containing 2.5% fetal bovine serum and 1 mmol/L dithiothreitol (Sigma, St. Louis, MO) to remove mucus. The mucosa was then incubated in medium containing 0.75 mmol/L ethylenediaminetetraacetic acid (Sigma) for 60 min at 37°C. During this treatment, intraepithelial lymphocytes and epithelial cells were released from the tissue, and tissue containing LPLs was collected and incubated in medium with 0.02% collagenase (Worthington Biochemical, Freehold, NJ). Fractions were pelleted twice through a 40% isotonic Percoll solution, and the cells were centrifuged over a Ficoll-Hypaque density gradient. The purity of resulting LPLs was analyzed by flow cytometry. Cell preparations were judged to be adequately pure, because ␣/␤ T cells made up 82%-96% of the CD3ϩ cell population in LPLs, and the CD4/CD8 ratio was more than 2.1 in LPLs. CD4ϩ T cells were isolated from single suspensions of LPLs in RPMI-1640 containing 2% fetal calf serum (FCS) using an anti-L3T4 (anti-CD4) Mini MACS magnetic separation system (Miltenyi Biotec, Suburn, CA), according to the manufacturer's instructions. Briefly, LPLs were incubated with anti-CD4 magnetic microbeads for 30 min on ice, washed, and then enriched by passage through magnetic flow columns (95% purity). They were then immediately used or cultured in medium for further experiments. For control samples, autologous peripheral blood lymphocytes were isolated by
Synergistic effect of IL-12 and IL-18 on LPLs density gradient centrifugation (Lymphoprep; Nycomed Pharma, Oslo, Norway) from 10 ml heparinized samples.
ELISA for Cytokines
Total IL-12 (p70 heterodimer plus p40 chains) and IL-18 levels within sera, and IFN-␥ concentrations within culture supernatant were measured by ELISA. The systems employed to measure IL-12 were purchased from Endogen (Cambridge, MA), the IFN-␥ ELISA kit was purchased from R&D Systems (Mineapolis, MN), and IL-18 ELISA was supplied from Hayashibara Biochemical Laboratories (28) .
Flow Cytometry
To perform staining of freshly isolated colonic LPLs and PBLs for expression of IL-2R␣, IL-12R␤1, ␤2, and IL-18R␣, 1 ϫ 10 6 cells were incubated with 20 l of 1 g/ml purified antihuman IL-2R␣ mAb (mouse IgG1), 20 l of 1 g/ml purified antihuman IL-12R␤1 mAb (mouse IgG1), 20 l of 1 g/ml purified antihuman IL-12R␤2 mAb (mouse IgG1), and 20 l of 1 g/ml purified antihuman IL-18R␣ mAb (mouse IgM), or 20 l of 1 g/ml isomatched mouse IgG or IgM mAb for 30 min on ice. After washing three times with phosphate-buffered saline, cells were incubated with 20 l of 1 g/ml FITC-conjugated goat antimouse IgG or IgM. After another round of washing, cells were incubated with 20 l of 1 g/ml PE-conjugated anti-CD3 mAb for 30 min on ice, after which the cells were suspended at 1 ϫ 10 6 cells/ml, and the intensity of fluorescence on the surface of the cells was analyzed with a FACScan (Becton Dickinson, Mountain View, CA).
Proliferation Assays
Proliferation assays were performed by culturing purified colon-derived LPLs and PBLs (5 ϫ 10 4 per well) in 96-well microtiter plates for 72 h as previously described (26) . After incubation, the cultures were pulsed for 7 h with [ 3 H]thymidine (0.5 Ci/well) (New England Nuclear, Boston, MA), harvested on glass fiber filters, and radioactivity was counted (in counts per min) in a liquid scintillation system. Recombinant human IL-12 and IL-18 were added alone or in combination to cultures as a stimulant. Blocking mAb against either IL-2, IL-2R␣, or IFN-␥ was added at the start of each assay at a final concentration of 5 g/ml.
Stimulation of IFN-␥ Production and IL-2R␣, IL-12R␤1, ␤2, and IL-18R␣ Expression in LPLs and PBLs
To assess the effect of IL-12 and IL-18 on IFN-␥ production by LPLs and PBLs, 3 ϫ 10 6 LPL and PBL cells were cultured in the presence or absence of either IL-12 (10 ng/ml) or IL-18 (100 ng/ml) in a total volume of 2.0 ml in 24-well plates for 72 h. At the end of each culture period, supernatant was collected.
The expression of IL-2R␣, IL-12R␤1, ␤2, and IL-18R␣ on LPLs and PBLs was examined by flow cytometry after LPLs and PBLs were cultured with recombinant IL-12 or IL-18 alone or in combination. Briefly, 3 ϫ 10 6 LPL and PBL cells/well (6-well culture plates) were cultured in the presence or absence of recombinant IL-12 (10 ng/ml) or IL-18 (100 ng/ml) alone or in combination for 48 h.
Statistical Analysis
Results were expressed as the mean Ϯ SD. Groups of data were compared using the Student's t test. Statistical significance was established at p Ͻ 0.05. To assess the correlation between serum IL-12 and IL-18 concentrations, Pearson's correlation coefficient test was used.
RESULTS
Correlation of Serum IL-12 and IL-18 Levels
IL-12 and IL-18 serum levels were significantly higher in CD patients (IL-12: 275.5 Ϯ 253.6 pg/ml, IL-18: 117.4 Ϯ 65.6 pg/ml) than in control subjects (IL-12: 71.2 Ϯ 63.7 pg/ml, IL-18: 21.7 Ϯ 14.4 pg/ml) (Fig. 1 ). There was a significant correlation between serum IL-12 and serum IL-18 concentrations in CD patients (r ϭ 0.62, p Ͻ 0.005).
Expression of IL-12R␤1, ␤2, and IL-18R␣ in Freshly Isolated LPLs and PBLs
As shown in Figure 2A , IL-12R␤1 and IL-18R␣ were constitutively expressed in LPLs from control subjects and CD patients; however, a very low level of IL-12R␤2 expression was noted in LPLs from control subjects, although the level was still significant. In contrast, in addition to IL-12R␤1 and IL-18R␣, IL-12R␤2 was clearly expressed in LPLs from CD patients. Moreover, a significantly greater level of IL-12R␤2 expression was noted in CD patients, compared with control subjects. IL-12R␤2 was not expressed in PBLs from control subjects or CD patients, although IL-12R␤1 was constitutively expressed in PBLs from control subjects and 
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Combined Stimulation With IL-12 and IL-18 Induced a Significant Increase in IFN-␥ Production
We measured IFN-␥ concentrations in the supernatant of lymphocytes stimulated with IL-12 and/or IL-18. Both IL-12 and IL-18 induced a limited amount of IFN-␥ production by LPLs from control subjects when given alone. IFN-␥ synthesis was consistently and markedly augmented by IL-18 and IL-12 combined. The production of IFN-␥ as a result of exposure to IL-12 alone, IL-18 alone, or a combination of both, was significantly greater in cultures of LPLs from CD patients than in cultures of LPLs from control subjects (p Ͻ 0.05) (Fig. 3A) . Neither IL-12 nor IL-18 alone induced IFN-␥ production in cultures of PBLs. On the other hand, combined stimulation with IL-12 and IL-18 induced a significant amount of IFN-␥ production in cultures of PBLs from both control subjects and CD patients. Furthermore, statistically significant differences in IFN-␥ production were not observed among the PBLs from control subjects and CD patients (Fig. 3B) .
Combined Stimulation With IL-12 and IL-18 Induced a Significant LPL Proliferative Response
To investigate the functional activity of macrophage-derived Th1 cytokines such as IL-12 and IL-18, we assessed the effect of exogenous recombinant IL-12 alone, IL-18 alone, and a combination of both, on the proliferation of freshly-isolated LPLs and PBLs. In control subjects, a significantly increased LPL proliferative response was observed after combined stimulation with IL-12 and IL-18; however, neither IL-12 nor IL-18 produced this effect on their own (Fig. 4A) . On the other hand, combined stimulation with IL-12 and IL-18, as well as stimulation with IL-12 and IL-18 alone, did not induce a PBL proliferative response in any of the same control subjects (Fig. 4B) . In CD patients, a significantly increased proliferative LPL response was observed by combined stimulation with IL-12 and IL-18, as well as stimulation with either IL-12 or IL-18 alone (p Ͻ 0.05) (Fig. 4A) . LPLs cultured in the presence of IL-12 (1 ng/ml) responded significantly to very low levels (picogram concentrations) of IL-18 in a synergistic manner (Fig. 4A ). This effect was particularly notable in CD patients.
We next enriched CD4ϩ LPLs to elucidate the specificity of various LPL responses to combined stimulation with IL-12 and IL-18. As shown in Figure 5 , the proliferative response of enriched CD4ϩ LPLs isolated from control subjects was significantly enhanced after combined stimulation with IL-12 and IL-18; however, a significant difference in the proliferative response of enriched CD4ϩ LPLs from control subjects was not observed after stimulation with either IL-12 or IL-18 alone. In CD patients, a significant increase in the proliferative response of CD4ϩ LPLs was observed after combined stimulation with IL-12 and IL-18, as well as after stimulation with IL-12 and IL-18 alone (p Ͻ 0.05) (Fig. 5) . CD4ϩ LPLs cultured in the presence of IL-12 (1 ng/ml) yielded a significant synergistic response with very low levels of IL-18. This was particularly notable in cultures of CD CD4ϩ LPLs.
Expression of IL-18R␣ in IL-12-Stimulated LPLs From CD Patients
To assess the mechanism by which IFN-␥ production and proliferative activity is synergistically enhanced by stimulation with IL-12 and IL-18, we examined IL-18R␣ expression in lymphocytes after 48 h culture in the presence or absence of IL-12. The expression of IL-18R␣ in LPLs from 
3111
AJG -December, 2002
Synergistic effect of IL-12 and IL-18 on LPLs control subjects and in PBLs from both control subjects and CD patients was not affected; however, IL-18R␣ expression was significantly increased in LPLs from CD patients after IL-12 stimulation, as shown in Figure 6 . On the contrary, IL-12R␤1 and IL-12R␤2 expression in LPLs and PBLs from control subjects and CD patients did not change in response to IL-18 stimulation, as shown in Figure 7A , B.
Expression of IL-2R␣ in LPLs After IL-12 and/or IL-18 Stimulation
To clarify the involvement of IL-2/IL-2R growth signaling in proliferative responses stimulated by IL-12 and/or IL-18, we assessed IL-2R␣ (CD25) expression in LPLs cultured in the presence or absence of both IL-12 and IL-18 for 48 h. Among unstimulated LPLs from control subjects, the expression of IL-2R␣ was not upregulated (Fig. 8A) ; however, a significant increase in the expression of IL-2R␣ was demonstrated in LPLs after culture with IL-12 alone, IL-18 alone, or IL-12 and IL-18 in combination. IL-2R␣ expression was significantly greater in both unstimulated and stimulated LPLs from CD patients, compared with control subjects. In contrast, IL-2R␣ expression in PBLs from both control subjects and CD patients was unchanged in the absence or presence of IL-12 and/or IL-18 (Fig. 8B) .
The Proliferative Response of LPLs After Combined Stimulation With IL-12 and IL-18 Was Inhibited by Anti-IL-2 mAb and Anti-IL-2R mAb
To further clarify the involvement of IL-2/IL-2R signals in the proliferative response of LPLs as a result of combined stimulation with IL-12 and IL-18, we next examined the effects of mAbs against IL-2, IL-2R␣ (CD25), and IFN-␥ with respect to proliferation. As shown in Figure 9A , the proliferative response of LPLs from control subjects after combined stimulation with IL-12 and IL-18 was partially but significantly inhibited by anti-IL-2 mAb and anti-IL-2R␣ mAb (% inhibition ϭ 59.5 Ϯ 9.4% and 63.9 Ϯ 10.6%, respectively) (p Ͻ 0.05). However, the addition of mAb against IFN-␥ hardly affected the proliferative response of LPLs from control subjects. These results suggest that IL-2/IL-2R growth signaling is involved in the proliferative response of LPLs to costimulation with IL-12 and IL-18. In CD LPLs, the proliferative response to IL-12 and/or IL-18 was also significantly inhibited by anti-IL-2 mAb and anti-IL-2R mAb (p Ͻ 0.05) (Fig. 9B) . Interestingly, the proliferative response to IL-12 and IL-18 alone was also partially inhibited by anti-IL-18 mAb and anti-IL-12 mAb, respectively (data not shown).
DISCUSSION
The results obtained in this study demonstrate that combined stimulation with IL-12 and IL-18 induces a significant proliferative response of LPLs from both CD patients and control subjects in the absence of TCR signaling. In contrast, combined stimulation with IL-12 and IL-18 did not induce a significant proliferative response of either PBLs isolated from CD patients or PBLs from control subjects. The different response of LPLs and PBLs to IL-12 and IL-18 might be explained by differences in their expression levels of IL-12R␤2 and IL-18R␣. In PBLs from control subjects, neither IL-12R␤2 nor IL-18R␣ was expressed. In contrast, IL-12R␤2 and IL-18R␣ were both expressed at low but significant levels in LPLs from control subjects. This suggests that T cell activation via combined stimulation with IL-12 and IL-18 might be an important pathway by which resting lamina propria T cells within the intestinal mucosa can be activated in the absence of antigen stimulation. and IL-18 function as a potent growth factor via a physiological mechanism, rather than through stimulation of TCRs in the intestinal mucosa, it also indicates that IL-12 and IL-18 stimulate CD4ϩ T cells directly. In addition, we showed that combined stimulation with IL-12 and IL-18 induces IL-2R␣ expression and that the proliferative response of LPLs isolated from control subjects to combined stimulation is partially inhibited by neutralizing anti-IL-2 mAb and anti-IL-2R␣ mAb. This data indicates that IL-2/ IL-2R growth signaling may be involved in the proliferative response of LPLs from control subjects to combined stimulation with IL-12 and IL-18. Furthermore, both IL-12 and IL-18 induced significant proliferative responses of LPLs from CD patients when administered alone, as well as in combination. Responses to IL-12 alone may be explained by the observed upregulation of IL-12R␤2 on LPLs from the inflamed mucosa of CD patients. Moreover, IL-18 responsiveness of LPLs from CD patients may be due to the observed upregulation of high affinity IL-18R, composed of IL-18R␣ and IL-18R␤. Interestingly, the responsiveness of LPLs isolated from CD pa- 
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Okazawa et al. AJG -Vol. 97, No. 12, 2002 tients to IL-12 and IL-18 alone was partially inhibited by neutralizing anti-IL-18 mAb and anti-IL-12 mAb, respectively. This suggests that IL-12 and IL-18 might induce production of a small amount of endogenous IL-18 and IL-12, respectively, although detectable levels of IL-12 or IL-18 were not found within the culture supernatant of LPLs by specific ELISA (data not shown). We next investigated whether the observed synergy between IL-12 and IL-18 on LPLs was related to the induction of IL-18R␣ expression by IL-12, as Ahn et al. have reportedly observed in a IL-12-dependent murine T cell line (2D6). In addition, naive murine T cells stimulated with anti-CD3 and anti-CD28 mAb have been shown to express IL-18R␣ after exposure to IL-12 (29) . Using flow cytometric analysis, we observed that IL-12R␤1, IL-12R␤2, and IL-18R␣ were constitutively expressed in LPLs from CD patients, and that IL-12 upregulated IL-18R␣ expression in these cells. In contrast, a lower level of IL-12R␤2 expression was observed in LPLs isolated from control subjects. This suggests that IL-12 failed to upregulate IL-18R␣ expression in LPLs from control subjects owing to the low expression of IL-12R␤2.
Alternatively, the observed synergy between the two cytokines might be explained by their relationship to postreceptor events. With regard to this possibility, IL-12 and IL-18 have recently been found to differentially regulate transcriptional activity of the human IFN-␥ promoter in primary CD4ϩ lymphocytes, with IL-18 causing a direct activation of AP-1, whereas IL-12-dependent IFN-␥ promotor activation required signal transducer and activation of transcription-4 (30) Thus, we assume that NF-B and STAT-4 synergistically activate the IFN-␥ promotor, resulting in a marked level of IFN-␥ production and proliferative activity. 
